Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
NCT07075510
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Plasma Cell Disorder
Interventions
DRUG:
Daratumumab Injection
Sponsor
University of Maryland, Baltimore
Collaborators
[object Object]